180 related articles for article (PubMed ID: 17543532)
1. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
2. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
5. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
7. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
8. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
9. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
[TBL] [Abstract][Full Text] [Related]
10. trans-Beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases.
Park J; Pei D
Biochemistry; 2004 Nov; 43(47):15014-21. PubMed ID: 15554709
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein tyrosine phosphatases PTP1B and CD45 by sulfotyrosyl peptides.
Desmarais S; Jia Z; Ramachandran C
Arch Biochem Biophys; 1998 Jun; 354(2):225-31. PubMed ID: 9637730
[TBL] [Abstract][Full Text] [Related]
12. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
Bialy L; Waldmann H
Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
[TBL] [Abstract][Full Text] [Related]
14. Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases.
Srinivasan R; Uttamchandani M; Yao SQ
Org Lett; 2006 Feb; 8(4):713-6. PubMed ID: 16468749
[TBL] [Abstract][Full Text] [Related]
15. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Amuso S; Wolber G; Schuster D; Herdlinger S; Manao G; Camici G; Paoli P
Eur J Med Chem; 2012 Apr; 50():332-43. PubMed ID: 22381357
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of functionalized acetophenones as protein tyrosine phosphatase 1B inhibitors.
Dixit M; Tripathi BK; Srivastava AK; Goel A
Bioorg Med Chem Lett; 2005 Jul; 15(14):3394-7. PubMed ID: 15951172
[TBL] [Abstract][Full Text] [Related]
17. N-(cyclohexanecarboxyl)-O-phospho-l-serine, a minimal substrate for the dual-specificity protein phosphatase IphP.
Savle PS; Shelton TE; Meadows CA; Potts M; Gandour RD; Kennelly PJ
Arch Biochem Biophys; 2000 Apr; 376(2):439-48. PubMed ID: 10775432
[TBL] [Abstract][Full Text] [Related]
18. In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones.
Rakowitz D; Maccari R; Ottanà R; Vigorita MG
Bioorg Med Chem; 2006 Jan; 14(2):567-74. PubMed ID: 16202614
[TBL] [Abstract][Full Text] [Related]
19. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
Bishop AC; Blair ER
Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
[TBL] [Abstract][Full Text] [Related]
20. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
